Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep 28;33(22):3894-904.
doi: 10.1002/sim.6193. Epub 2014 Apr 15.

Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials

Affiliations

Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials

David Boren et al. Stat Med. .

Abstract

Important sources of variation in the spread of HIV in communities arise from overlapping sexual networks and heterogeneity in biological and behavioral risk factors in populations. These sources of variation are not routinely accounted for in the design of HIV prevention trials. In this paper, we use agent-based models to account for these sources of variation. We illustrate the approach with an agent-based model for the spread of HIV infection among men who have sex with men in South Africa. We find that traditional sample size approaches that rely on binomial (or Poisson) models are inadequate and can lead to underpowered studies. We develop sample size and power formulas for community randomized trials that incorporate estimates of variation determined from agent-based models. We conclude that agent-based models offer a useful tool in the design of HIV prevention trials.

Keywords: HIV; community randomized trials; epidemics; networks; sample size.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Empirical variances of proportions infected in 5 years (P^) for a given θ, versus fitted proportions (from equation 8). The figure shows 162 data points where each data point refers to a different combination of HIV prevention interventions. The empirical variances were based on replicate runs for each of those combinations (the figure is based on 2157 runs of the agent based model). Also shown is the fitted variance function from equation 9 (var(P^θ)=0.5205P(θ)0.1127P(θ)3) and the naïve binomial variance. The fitted proportions are based on equation 8 with β0=−1.086, β1=−.000936, β2=−.00266, β3= −.04137, β4 =.000642, β5=−.0000087, β6=−.00119
Figure 2
Figure 2
The variance of the proportion in the study sample that become infected, var(p^θ), plotted versus fitted proportions (from equation 8). The variance is shown decomposed into the random sampling and stochastic epidemic components with sample sizes n=50, 100 and 200.
Figure 3
Figure 3
Power versus the effect size (percent of infections prevented(100(P1P2)/P1)) = (ε × 100) with α=.05, P1=.264, sample size n=50, 100 and 200 for k= 5 clusters (Panel A) and k=10 clusters (Panel B) in each arm.
Figure 4
Figure 4
Number of clusters per arm (k) needed to obtain 90% power to detect effect sizes (percent infections prevented, ε × 100) of 25%, 35% and 50%, with α=.05 and P1=.264 versus sample size n.

References

    1. Bekker LG, Beyrer C, Quinn TC. Behavioral and biomedical combination strategies for HIV prevention. Cold Spring Harbor Perspectives in Medicine. 2012;2(8):a007435. DOI: 10.1101/cshperspect.a007435. - PMC - PubMed
    1. Sullivan PS, Carballo-Diéguez A, Coates T, Goodreau SM, McGowan I, Sanders EJ, Smith A, Goswami P, Sanchez J. Successes and challenges of HIV prevention in men who have sex with men. The Lancet. 2012;380(9839):388–399. DOI:10.1016/S0140-6736(12)60955-6. - PMC - PubMed
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR. Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine. 2011;365(6):493–505. DOI: 10.1056/NEJMoa1105243. - PMC - PubMed
    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernandez T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker L, Mayer KH, Kallas EG, Amico R, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell J, Zheng J, Lee J, Rooney JF, Jafe HS, Martinez AI, Burns DN, Glidden DV. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010;363(27):2587–2599. DOI: 10.1056/NEJMoa1011205. - PMC - PubMed
    1. Lagakos SW, Gable AR. Challenges to HIV prevention--seeking effective measures in the absence of a vaccine. New England Journal of Medicine. 2008;358(15):1543–1545. DOI: 10.1056/NEJMp0802028. - PubMed

Publication types

LinkOut - more resources